{"sourcedb":"DevicePMAs@therightstef","sourceid":"P050047_S005","text":"Approval for the addition of 0.3% lidocaine into juvederm ultra and juvederm ultra plus.  The device, as modified, will be marketed under the trade name juvederm ultra xc and juvederm ultra plus xc and is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).","project":"consensus_PMA_Age_Indications"}